Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema

Show other versions (1)

A retrospective observational clinical study to evaluate the safety and effectiveness of the injectable 0.19-mg fluocinolone acetonide intravitreal implant (ILUVIEN) in the treatment of non-infectious uveitic macular edema.

Saved in:

Bibliographic Details
Main Authors:	Weber, Lea F. (Author) , Marx, Stefanie (Author) , Auffarth, Gerd U. (Author) , Scheuerle, Alexander F. (Author) , Tandogan, Tamer (Author) , Mayer, Christian (Author) , Khoramnia, Ramin (Author)
Format:	Article (Journal)
Language:	English
Published:	29 January 2019
In:	Journal of ophthalmic inflammation and infection Year: 2019, Volume: 9
ISSN:	1869-5760
DOI:	10.1186/s12348-019-0168-9
Online Access:	Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12348-019-0168-9
Author Notes:	Lea F. Weber, Stefanie Marx, Gerd U. Auffarth, Alexander F. Scheuerle, Tamer Tandogan, Christian Mayer and Ramin Khoramnia

Description
Summary:	A retrospective observational clinical study to evaluate the safety and effectiveness of the injectable 0.19-mg fluocinolone acetonide intravitreal implant (ILUVIEN) in the treatment of non-infectious uveitic macular edema.
Item Description:	Gesehen am 20.09.2019
Physical Description:	Online Resource
ISSN:	1869-5760
DOI:	10.1186/s12348-019-0168-9